657 related articles for article (PubMed ID: 2550548)
21. Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine.
Harvath L; McCall CE; Bass DA; McPhail LC
J Immunol; 1987 Nov; 139(9):3055-61. PubMed ID: 2822802
[TBL] [Abstract][Full Text] [Related]
22. Functional integrity of cytokineplasts: specific chemotactic and capping responses.
Dyett DE; Malawista SE; Van Blaricom G; Melnick DA; Malech HL
J Immunol; 1985 Sep; 135(3):2090-4. PubMed ID: 2991379
[TBL] [Abstract][Full Text] [Related]
23. Increasing extracellular potassium causes calcium-dependent shape change and facilitates concanavalin A capping in human neutrophils.
Roberts RL; Mounessa NL; Gallin JI
J Immunol; 1984 Apr; 132(4):2000-6. PubMed ID: 6699404
[TBL] [Abstract][Full Text] [Related]
24. Formyl peptide-induced chemotaxis of human polymorphonuclear leukocytes does not require either marked changes in cytosolic calcium or specific granule discharge. Role of formyl peptide receptor reexpression (or recycling).
Perez HD; Elfman F; Marder S; Lobo E; Ives HE
J Clin Invest; 1989 Jun; 83(6):1963-70. PubMed ID: 2723068
[TBL] [Abstract][Full Text] [Related]
25. Deactivation of guinea pig pulmonary alveolar macrophage responses to N-formyl-methionyl-leucyl-phenylalanine: chemotaxis, superoxide generation, and binding.
Daughaday CC; Mehta J; Spilberg I; Atkinson JP
J Immunol; 1985 Mar; 134(3):1823-6. PubMed ID: 2981922
[TBL] [Abstract][Full Text] [Related]
26. Nonsteroidal anti-inflammatory drug as tools for analysis of neutrophil functions.
Périanin A; Giroud JP; Hakim J
Biomed Pharmacother; 1987; 41(6):315-21. PubMed ID: 3446289
[TBL] [Abstract][Full Text] [Related]
27. Specific binding of leukotriene B4 to receptors on human polymorphonuclear leukocytes.
Goldman DW; Goetzl EJ
J Immunol; 1982 Oct; 129(4):1600-4. PubMed ID: 6286770
[TBL] [Abstract][Full Text] [Related]
28. Leukocyte inhibitory factor (LIF) potentiates human macrophage aggregation and activation responses to calcium ionophore A23187 and directly induces leukotriene B4 and thromboxane A2 release.
Conti P; Barbacane RC; Reale M; Panara MR; Placido FC; Mier JW; Castracane JM; Dempsey RA
Biotechnol Ther; 1993; 4(3-4):239-52. PubMed ID: 8292972
[TBL] [Abstract][Full Text] [Related]
29. Human monocyte adherence: a primary effect of chemotactic factors on the monocyte to stimulate adherence to human endothelium.
Doherty DE; Haslett C; Tonnesen MG; Henson PM
J Immunol; 1987 Mar; 138(6):1762-71. PubMed ID: 3819394
[TBL] [Abstract][Full Text] [Related]
30. Neutrophil degranulation: evidence pertaining to its mediation by the combined effects of leukotriene B4, platelet-activating factor, and 5-HETE.
O'Flaherty JT
J Cell Physiol; 1985 Feb; 122(2):229-39. PubMed ID: 2981891
[TBL] [Abstract][Full Text] [Related]
31. Generation of leukotrienes by human monocytes pretreated with cytochalasin B and stimulated with formyl-methionyl-leucyl-phenylalanine.
Williams JD; Robin JL; Lewis RA; Lee TH; Austen KF
J Immunol; 1986 Jan; 136(2):642-8. PubMed ID: 3001181
[TBL] [Abstract][Full Text] [Related]
32. Neutrophil chemotactic factors promote leukocytosis. A common mechanism for cellular recruitment from bone marrow.
Jagels MA; Hugli TE
J Immunol; 1992 Feb; 148(4):1119-28. PubMed ID: 1310708
[TBL] [Abstract][Full Text] [Related]
33. Selected antibodies to leukocyte common antigen (CD45) inhibit human neutrophil chemotaxis.
Harvath L; Balke JA; Christiansen NP; Russell AA; Skubitz KM
J Immunol; 1991 Feb; 146(3):949-57. PubMed ID: 1671052
[TBL] [Abstract][Full Text] [Related]
34. Human C5a modulates monocyte Fc and C3 receptor expression.
Yancey KB; O'Shea J; Chused T; Brown E; Takahashi T; Frank MM; Lawley TJ
J Immunol; 1985 Jul; 135(1):465-70. PubMed ID: 3158706
[TBL] [Abstract][Full Text] [Related]
35. Platelet-activating factor production in human neutrophils by sequential stimulation with granulocyte-macrophage colony-stimulating factor and the chemotactic factors C5A or formyl-methionyl-leucyl-phenylalanine.
Wirthmueller U; De Weck AL; Dahinden CA
J Immunol; 1989 May; 142(9):3213-8. PubMed ID: 2540238
[TBL] [Abstract][Full Text] [Related]
36. IL-8 production by human polymorphonuclear leukocytes. The chemoattractant formyl-methionyl-leucyl-phenylalanine induces the gene expression and release of IL-8 through a pertussis toxin-sensitive pathway.
Cassatella MA; Bazzoni F; Ceska M; Ferro I; Baggiolini M; Berton G
J Immunol; 1992 May; 148(10):3216-20. PubMed ID: 1578146
[TBL] [Abstract][Full Text] [Related]
37. Analysis of density changes and chemotactic receptors of leukocytes from chronic hemodialysis and peritoneal dialysis patients.
Lewis SL; Van Epps DE; Chenoweth DE
Blood Purif; 1987; 5(2-3):138-54. PubMed ID: 3040039
[TBL] [Abstract][Full Text] [Related]
38. Stimulation of type II adenylyl cyclase by chemoattractant formyl peptide and C5a receptors.
Tsu RC; Allen RA; Wong YH
Mol Pharmacol; 1995 Apr; 47(4):835-41. PubMed ID: 7723745
[TBL] [Abstract][Full Text] [Related]
39. Recognition of human polymorphonuclear leukocyte receptors for leukotriene B4 by rabbit anti-idiotypic antibodies to a mouse monoclonal antileukotriene B4.
Gifford LA; Chernov-Rogan T; Harvey JP; Koo CH; Goldman DW; Goetzl EJ
J Immunol; 1987 Feb; 138(4):1184-9. PubMed ID: 3027172
[TBL] [Abstract][Full Text] [Related]
40. Granulocytes from chronic myeloid leukemia (CML) patients show differential response to different chemoattractants.
Radhika V; Thennarasu S; Naik NR; Kumar A; Advani SH; Bhisey AN
Am J Hematol; 1996 Jul; 52(3):155-64. PubMed ID: 8756080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
